Registrar's Guide to Updating Radiation Data Items
Keeping in mind that the use of data should always be the ultimate driver of rules for coding, this introduction to Version 2.0 of the CTR Guide to Coding Radiation Therapy will focus on why this data is collected and how it will be used. We will discuss experience-driven changes to the Standards for Oncology Registry Entry (STORE), coding guidelines, and the content in this guide, in which the number of case studies has more than doubled compared to Version 1.0. We will review a summary of general rules of coding radiation, discuss and illustrate selected new cases, and review available options when you don’t know how to code a case.
- Cancer Tumor Registrars
- Goals of radiation therapy coding in STORE
- Updates in the latest edition of the CTR guide
- New radiation technologies, how to code them
- For questions about the course, please contact CoC@facs.org.
- For questions about the CoC, NAPBC, or NAPRC Standards, submit questions in the CAnswer Forum.
- If you have any technical questions, contact firstname.lastname@example.org.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as an “ineligible company”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Speaker and Moderator Disclosures
Ted Williamson, MD, PhD, CTR - Nothing to disclose
Dr. Williamson began his career in 1968 as a physics professor at the U.S. Naval Postgraduate school in Monterey, CA. During this tenure, he became the consulting physicist in the new radiation oncology department at the Community Hospital of the Monterey Peninsula in Carmel. There Dr. Williamson discovered the satisfaction of direct patient care and the related importance and value of cancer registry. This experience changed his compass. After completing medical school at the University of Miami and residency at the University of Washington, Dr. Williamson joined the radiation oncology practice in Salem, OR. His participation with the Commission on Cancer in registry issues began with the ROADS development committee in 1992 and continues to the present time. Dr. Williamson earned his CTR credential in 1993.
Program Committee Disclosures
Ryan McCabe - Nothing to disclose
Susanne Kessler - Nothing to disclose
Delores Akins - Nothing to disclose
Cindy Traylor-Richards - Nothing to disclose
Asa Carter - Nothing to disclose
Andrea Scrementi - Nothing to disclose
Chantel Ellis - Nothing to disclose
A Certificate of Completion will be awarded for this course.
1 continuing education credit for #2020-166 will be provided from National Cancer Registrars Association (NCRA).
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 1 contact hour.
- 1.00 CE Contact hours
- 1.00 Certificate of Completion